Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer

Life Sciences

Volumn 159, Issue , 2016, Pages 49-54

  Tocci, Piera ^a   Caprara, Valentina ^a   Cianfrocca, Roberta ^a   Sestito, Rosanna ^a   Di Castro, Valeriana ^a   Bagnato, Anna ^a   Rosanò, Laura ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Endothelin; Ovarian cancer; RhoA

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACTIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; FASUDIL; MACITENTAN; MYOSIN; MYOSIN LIGHT CHAIN 2; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ACTIN FILAMENT; ARTICLE; ASSAY; CANCER CELL LINE; CELL MIGRATION; CELL MOTILITY; CHEMOTAXIS ASSAY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; KINASE ASSAY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PSEUDOPODIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WOUND HEALING ASSAY; ENZYMOLOGY; METABOLISM; NEOPLASM; OVARY TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RECEPTOR, ENDOTHELIN A; RHOA GTP-BINDING PROTEIN;

EID: 84954290049     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.01.008     Document Type: Article

References (36)

1. [1] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J. Clin. 65 (2015), 5–29.
2. [2] Rosanò, L., Spinella, F., Bagnato, A., Endothelin 1 in cancer: biologicalimplications and therapeutic opportunities. Nat. Rev. Cancer 9 (2013), 637–651.
3. [3] Rosanò, L., Varmi, M., Salani, D., Di Castro, V., Spinella, F., Natali, P.G., Bagnato, A., Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res. 61 (2001), 8340–8346.
4. [4] Said, N., Smith, S., Sanchez-Carbayo, M., Theodorescu, D., Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. J. Clin. Invest. 47 (2011), 132–147.
5. [5] Wu, M.H., Lo, J.F., Kuo, C.H., Lin, J.A., Lin, Y.M., Chen, L.M., Tsai, F.J., Tsai, C.H., Huang, C.Y., Tang, C.H., Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways. J. Cell. Physiol. 227 (2012), 3016–3026.
6. [6] Knowles, J.P., Shi-Wen, X., Haque, S.U., Bhalla, A., Dashwood, M.R., Yang, S., Taylor, I., Winslet, M.C., Abraham, D.J., Loizidou, M., Endothelin-1 stimulates colon cancer adjacent fibroblasts. Int. J. Cancer 130 (2012), 1264–1272.
7. [7] Ha, N.H., Nair, V.S., Reddy, D.N., Mudvari, P., Ohshiro, K., Ghanta, K.S., Pakala, S.B., Li, D.Q., Costa, L., Lipton, A., Badwe, R.A., Fuqua, S., Wallon, M., Prendergast, G.C., Kumar, R., Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes. Cancer Res. 71 (2011), 7259–7269.
8. [8] Hinsley, E.E., Kumar, S., Hunter, K.D., Whawell, S.A., Lambert, D.W., Endothelin-1 stimulates oral fibroblasts to promote oral cancer invasion. Life Sci. 91 (2012), 557–561.
9. [9] Spinella, F., Caprara, V., Cianfrocca, R., Rosanò, L., Di Castro, V., Garrafa, E., Natali, P.G., Bagnato, A., The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor. Carcinogenesis 35 (2014), 840–848.
10. [10] Hsieh, W.T., Yeh, W.L., Cheng, R.Y., Lin, C., Tsai, C.F., Huang, B.R., Wu, C.Y., Lin, H.Y., Huang, S.S., Lu, D.Y., Exogenous endothelin-1 induces cell migration and matrix metalloproteinaseexpression in U251 human glioblastoma multiforme. J. Neuro-Oncol. 118 (2014), 257–269.
11. [11] Teoh, J.P., Park, K.M., Wang, Y., Hu, Q., Kim, S., Wu, G., Huang, S., Maihle, N., Kim, I.M., Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. Cell. Signal. 26 (2014), 2885–2895.
12. [12] Shukla, A.K., Xiao, K., Lefkowitz, R.J., Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem. Sci. 36 (2011), 457–469.
13. [13] Rosanò, L., Cianfrocca, R., Masi, S., Spinella, F., Di Castro, V., Birocci, A., Salvati, E., Nicotra, M.R., Natali, P.G., Bagnato, A., β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 2806–2811.
14. [14] Rosanò, L., Cianfrocca, R., Tocci, P., Spinella, F., Di Castro, V., Spadaro, F., Salvati, E., Biroccio, A.M., Natali, P.G., Bagnato, A., β-Arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. Oncogene 32 (2013), 5066–5077.
15. [15] Spinella, F., Caprara, V., Di Castro, V., Rosanò, L., Cianfrocca, R., Natali, P.G., Bagnato, A., Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells. J. Mol. Med. 91 (2013), 395–405.
16. [16] Rosanò, L., Cianfrocca, R., Tocci, P., Spinella, F., Di Castro, V., Caprara, V., Semprucci, E., Ferrandina, G., Natali, P.G., Bagnato, A., Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. Cancer Res. 74 (2014), 7453–7464.
17. [17] Min, J., Defea, K.A., β-Arrestin-dependent actin reorganization: bringing the right players together at the leading edge. Mol. Pharmacol. 80 (2011), 760–768.
18. [18] Defea, K.A., Arrestins in actin reorganization and cell migration. Prog. Mol. Biol. Transl. Sci. 118 (2013), 205–222.
19. [19] Hall, A., The cytoskeleton and cancer. Cancer Metastasis Rev. 28 (2009), 5–14.
20. [20] Spiering, D., Hodgson, L., Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adhes. Migr. 2 (2011), 1–11.
21. [21] S.J. Heasman, A.J. Ridley, Mammalian Rho GTPases: new insights into their functions from in vivo studies, Nat. Rev. Mol. Cell Biol. 9 (2008) 690–701.
22. [22] Ridley, A.J., RhoA, RhoB and RhoC have different roles in cancer cell migration. J. Microsc. 251 (2013), 242–249.
23. [23] Sahai, E., Marshall, C.J., RHO-GTPases and cancer. Nat. Rev. Cancer 2 (2002), 133–142.
24. [24] Rosanò, L., Cianfrocca, R., Spinella, F., Di Castro, V., Nicotra, M.R., Lucidi, A., Ferrandina, G., Natali, P.G., Bagnato, A., Acquisition of chemoresistance and EMT phenotypeislinked with activation of the endothelin A receptorpathway in ovarian carcinoma cells. Clin. Cancer Res. 17 (2011), 2350–2360.
25. [25] Amano, M., Ito, M., Kimura, K., Fukata, Y., Kihara, K., Nakano, T., Matsuura, Y., Kaibuchi, K., Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271 (1996), 20246–202499.
26. [26] Kimura, K., Ito, M., Amano, M., Kihara, K., Fukata, Y., Nakafufu, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., Iwamatsu, A., Kaibuchi, K., Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273 (1996), 245–248.
27. [27] Cho, S.Y., Klemke, R.L., Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold. J. Cell Biol. 156 (2002), 725–736.
28. [28] Jelovac, D., Armstrong, K.D.K., Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J. Clinic. 61 (2011), 183–203.
29. [29] Yu, O.M., Brown, J.H., G protein-coupled receptor and RhoA-stimulated transcriptional responses: links to inflammation, differentiation, and cell proliferation. Mol. Pharmacol. 88 (2015), 171–180.
30. 12/13-coupled receptors. Br. J.Pharmacol. 158 (2009), 41–49.
31. [31] Violin, J.D., Lefkowitz, R.J., Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28 (2007), 416–422.
32. [32] W.G. Barnes, E. Reiter, J.D. Violin, X.R. Ren, G. Milligan, R.J. Lefkowitz, Beta-arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem. 2005 Mar 4;280(9):8041–50.
33. [33] X. Ma, Y. Zhao, Y. Daaka, Z. Nie, Acute activation of β2-adrenergic receptor regulates focal adhesions through βArrestin2- and p115RhoGEF protein-mediated activation of RhoA. J Biol Chem. 287 (2012) 18925–18936.
34. [34] Anthony, D.F., Sin, Y.Y., Vadrevu, S., Advant, N., Day, J.P., Byrne, A.M., Lynch, M.J., Milligan, G., Houslay, M.D., Baillie, G.S., β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II Type 1A receptor stimulation. Mol. Cell. Biol. 31 (2011), 1066–1075.
35. [35] Bhattacharya, M., Anborgh, P.H., Babwah, A.V., Dale, L.B., Dobransky, T., Benovic, J.L., Feldman, R.D., Verdi, J.M., Rylett, R.J., Ferguson, S.S., Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat. Cell Biol. 4 (2002), 547–555.
36. [36] Parisis, N., Metodieva, G., Metodiev, M.V., Pseudopodial and β-arrestin-interacting proteomes from migrating breast cancer cells upon PAR2 activation. J. Proteomics. 80 (2013), 91–106.